(Q54504827)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22690797%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

title

Phosphorylated 4E-binding protein 1 (p-4E-BP1): a novel prognostic marker in human astrocytomas (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22690797%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

0 references

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22690797%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Elias El-Habr

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22690797%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

author name string

Penelope Korkolopoulou

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22690797%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Georgia Levidou

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22690797%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Christina Piperi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22690797%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Christos Adamopoulos

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22690797%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Vassilis Samaras

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22690797%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Efstathios Boviatsis

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22690797%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Irene Thymara

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22690797%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Eleni-Andriana Trigka

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22690797%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Stratigoula Sakellariou

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22690797%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Nikolaos Kavantzas

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22690797%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Efstratios Patsouris

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22690797%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

publication date

13 June 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22690797%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22690797%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

volume

61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22690797%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22690797%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

page(s)

293-305

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22690797%20AND%20SRC:MED&resulttype=core&format=json

mTOR and cancer: reason for dancing at the crossroads?

4 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04236.X

Ras, PI(3)K and mTOR signalling controls tumour cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04236.X

Upstream and downstream of mTOR

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04236.X

Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04236.X

New Hierarchical Phosphorylation Pathway of the Translational Repressor eIF4E-binding Protein 1 (4E-BP1) in Ischemia-Reperfusion Stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04236.X

eIF-4E expression and its role in malignancies and metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04236.X

Rapamycin suppresses 5'TOP mRNA translation through inhibition of p70s6k.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04236.X

Targeting the mTOR signaling network for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04236.X

Growing roles for the mTOR pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04236.X

TOR, a central controller of cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04236.X

Expression of pERK and pAKT in human astrocytomas: correlation with IDH1-R132H presence, vascular endothelial growth factor, microvascular characteristics and clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04236.X

Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04236.X

The 2007 WHO classification of tumours of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04236.X

Characterization of R132H mutation-specific IDH1 antibody binding in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04236.X

4E-binding protein 1, a cell signaling hallmark in breast cancer that correlates with pathologic grade and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04236.X

High expression of phosphorylated 4E-binding protein 1 is an adverse prognostic factor in esophageal squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04236.X

Hypoxia-inducible factor 1alpha/vascular endothelial growth factor axis in astrocytomas. Associations with microvessel morphometry, proliferation and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04236.X

Sample-size calculations for the Cox proportional hazards regression model with nonbinary covariates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04236.X

Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04236.X

Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04236.X

Disruption of parallel and converging signaling pathways contributes to the synergistic antitumor effects of simultaneous mTOR and EGFR inhibition in GBM cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04236.X

The prognostic significance of phosphatidylinositol 3-kinase pathway activation in human gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04236.X

Prognostic associations of activated mitogen-activated protein kinase and Akt pathways in glioblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04236.X

Signal transduction molecules in gliomas of all grades

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04236.X

Mammalian target of rapamycin signaling pathway contributes to glioma progression and patients' prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04236.X

AKT activation in human glioblastomas enhances proliferation via TSC2 and S6 kinase signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04236.X

S6K1(-/-)/S6K2(-/-) mice exhibit perinatal lethality and rapamycin-sensitive 5'-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04236.X

4E-BP1 is a key effector of the oncogenic activation of the AKT and ERK signaling pathways that integrates their function in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04236.X

Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04236.X

Overexpression of phosphorylated mammalian target of rapamycin predicts lymph node metastasis and prognosis of chinese patients with gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04236.X

A hypoxia-controlled cap-dependent to cap-independent translation switch in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04236.X

Inhibition of 4E-BP1 sensitizes U87 glioblastoma xenograft tumors to irradiation by decreasing hypoxia tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04236.X

Overexpression of phosphorylated 4E-BP1 predicts for tumor recurrence and reduced survival in cervical carcinoma treated with postoperative radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04236.X

Phospho-mTOR and phospho-4EBP1 in endometrial adenocarcinoma: association with stage and grade in vivo and link with response to rapamycin treatment in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04236.X

4E-binding protein 1: a key molecular "funnel factor" in human cancer with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04236.X

Targeting the RTK-PI3K-mTOR axis in malignant glioma: overcoming resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04236.X

Modulation of 4E-BP1 function as a critical determinant of enzastaurin-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04236.X